Merck News

Merck (MRK) Gains As Market Dips: What You Should Know

zacks.com · Jun 26, 2026

Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It

zacks.com · Jun 26, 2026

Qualcomm, Merck, Rockwell Automation And A Real Estate Stock On CNBC's ‘Final Trades'

benzinga.com · Jun 26, 2026

The Big 3: JPM, DHR, MRK

youtube.com · Jun 25, 2026

MRK Gets EU Nod for Keytruda & Padcev Combination in Bladder Cancer

zacks.com · Jun 25, 2026

FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each with Trodelvy® (sacituzumab govitecan-hziy) as First-Line Treatment of PD-L1+ (CPS ≥10) Advanced Triple-Negative Breast Cancer (TNBC)

businesswire.com · Jun 25, 2026

Gilead Wins EC Approval to Expand Trodelvy's Label in Metastatic TNBC

zacks.com · Jun 24, 2026

Here Are Wednesday’s Best Wall Street Analyst Research Calls: Devon Energy, Flowserve, Klaviyo, Macerich, Merck, Nucor, Take-Two Interactive Software, Twilio, and More

247wallst.com · Jun 24, 2026

European Commission Approves KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First PD-1 Inhibitor Plus Antibody-Drug Conjugate Regimen for Adults With Cisplatin-Ineligible Resectable Muscle-Invasive Bladder Cancer

businesswire.com · Jun 24, 2026

EXEL Down on Colorectal Cancer Study Data on Zanzalintinib

zacks.com · Jun 23, 2026

Merck's Anti-TL1A Antibody Meets Goal in Ulcerative Colitis Study

zacks.com · Jun 23, 2026

Merck and Mae Partner to Expand Doula Workforce and Address Maternal Health Disparities in High-Risk U.S. Markets

businesswire.com · Jun 23, 2026

Bank of America Sees Interest Rates Exploding Higher Soon: Play It Safe With 4 Dividend Giants

247wallst.com · Jun 23, 2026

AbbVie and Merck Face-Off: Which Pharma Stock Has the Lead?

zacks.com · Jun 22, 2026

Merck's Oncology Engine Is Still Accelerating

seekingalpha.com · Jun 22, 2026

Merck's bowel disease drug meets main goal in late-stage trial

reuters.com · Jun 22, 2026

Merck's Tulisokibart Met Primary and Key Secondary Endpoints in the Phase 3 ATLAS-UC Induction-only Study in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

businesswire.com · Jun 22, 2026

Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to Know

zacks.com · Jun 18, 2026

FDA Expands Merck Pneumococcal Shot Label To Include At-Risk Children And Teens

benzinga.com · Jun 18, 2026

Merck's pneumococcal vaccine wins US approval for high-risk children, teens

reuters.com · Jun 18, 2026

U.S. FDA Approves an Additional Indication for CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in Children and Adolescents Aged 2 through 17 at Increased Risk for Pneumococcal Disease

businesswire.com · Jun 18, 2026

Study Reveals Dog Owners and Veterinarians See Challenges in Treating Allergic Skin Disease, Highlighting a Need for a Targeted Rapid Onset Treatment for Dogs of All Ages

businesswire.com · Jun 17, 2026

FDA Accepts Gilead's Filing for Weekly Oral Yeztugo for HIV Prevention

zacks.com · Jun 16, 2026

Protillion Biosciences Announces Drug Discovery Collaboration with Merck

businesswire.com · Jun 16, 2026

Merck: Buy The Dip On This Dividend Growth Pharma Leader

seekingalpha.com · Jun 16, 2026

3 Dividend Stocks to Hold for the Long Haul

fool.com · Jun 16, 2026

FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With WELIREG® (belzutifan), for Adjuvant Treatment of Certain Patients With Clear Cell Renal Cell Carcinoma (ccRCC)

businesswire.com · Jun 12, 2026

Is It Worth Investing in Merck (MRK) Based on Wall Street's Bullish Views?

zacks.com · Jun 12, 2026

Merck (MRK) Rises Yet Lags Behind Market: Some Facts Worth Knowing

zacks.com · Jun 11, 2026

Pharma and Biotech M&A Boom Accelerates as Companies Expand Pipelines

zacks.com · Jun 11, 2026

Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know

zacks.com · Jun 11, 2026

Lexicon Pharmaceuticals vs. Pfizer: Which Drugmaker Stock Is a Better Buy in 2026?

fool.com · Jun 11, 2026

Healthcare ETFs: From Broad Exposure to Big Breakthroughs

etftrends.com · Jun 11, 2026

Merck Animal Health to Acquire TARGAN

businesswire.com · Jun 11, 2026

Merck Stock Moves Above 50-Day SMA: Assessing Its Investment Case

zacks.com · Jun 10, 2026

Gilead, Merck Report Positive Phase III HIV Study Data, End NSCLC Study

zacks.com · Jun 9, 2026

Merck & Co., Inc. (MRK) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

seekingalpha.com · Jun 9, 2026

Gilead And Merck End Trodelvy-Keytruda Lung Cancer Trial

benzinga.com · Jun 9, 2026

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

forbes.com · Jun 9, 2026

Gilead and Merck Announce Positive Topline Results From Two Phase 3 Studies Evaluating Islatravir/Lenacapavir, an Oral Once-Weekly HIV Treatment

businesswire.com · Jun 8, 2026

Merck and Gilead Provide Update on Phase 3 KEYNOTE-D46/EVOKE-03 Study

businesswire.com · Jun 8, 2026

Rejuvenate Bio Announces $6 Million Financing and Strategic R&D Collaboration with Merck Animal Health

businesswire.com · Jun 8, 2026

Mizuho Strategist: Healthcare Is Now a Value Sector as Pharma Stocks Underperform Tech

247wallst.com · Jun 7, 2026

The Smartest Dividend ETF to Buy With $1,000 Right Now -- and It's Up 19% in 2026

fool.com · Jun 6, 2026

Dividend Champion, Contender, And Challenger Highlights: Week Of June 7

seekingalpha.com · Jun 5, 2026

Why Health Care's Seasonal Tailwind Looks Especially Compelling This Year

zacks.com · Jun 5, 2026

Merck & Co.: Why The Market Is Right To Start Buying Into Post-Keytruda Promise

seekingalpha.com · Jun 5, 2026

Dividend ETFs: SCHD Boasts a Larger Dividend Yield, While VIG Has Lower Fees

fool.com · Jun 5, 2026

Merck (MRK) Recently Broke Out Above the 20-Day Moving Average

zacks.com · Jun 5, 2026

Merck (MRK) Crossed Above the 50-Day Moving Average: What That Means for Investors

zacks.com · Jun 5, 2026

Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech

fool.com · Jun 5, 2026

Merck: Navigating the Patent Cliff and Future Growth Prospects

fool.com · Jun 4, 2026

Merck & Co., Inc. (MRK) Presents at Jefferies Global Healthcare Conference 2026 Transcript

seekingalpha.com · Jun 4, 2026

Pfizer vs Merck: Chasing High Yield vs Higher Returns

247wallst.com · Jun 3, 2026

Merck & Co., Inc. (MRK) Discusses Oncology Strategy and Program Update With Focus on Clinical Progress and Pipeline Diversification Transcript

seekingalpha.com · Jun 2, 2026

Merck to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

businesswire.com · Jun 2, 2026

Merck's Calderasib Gets FDA's Breakthrough Therapy Tag for NSCLC

zacks.com · Jun 1, 2026

Merck exec says company is discussing use of COVID antiviral drug in Ebola response

reuters.com · Jun 1, 2026

Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting

accessnewswire.com · Jun 1, 2026

This Emerging Risk Is Unlike Anything the Biotech Industry Has Ever Experienced

fool.com · May 31, 2026